Patents by Inventor Mahan Abbasian

Mahan Abbasian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20240034789
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: February 1, 2023
    Publication date: February 1, 2024
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • SIRP-? binding proteins and methods of use thereof
    Patent number: 11591390
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: February 28, 2023
    Assignee: Celgene Corporation
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout
  • BCMA-BINDING ANTIBODIES AND USES THEREOF
    Publication number: 20220324991
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Application
    Filed: June 17, 2022
    Publication date: October 13, 2022
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • BCMA-binding antibodies and uses thereof
    Patent number: 11401336
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Grant
    Filed: February 20, 2019
    Date of Patent: August 2, 2022
    Assignee: CELGENE CORPORATION
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • BCMA-BINDING ANTIBODIES AND USES THEREOF
    Publication number: 20200399386
    Abstract: Antibody species that bind B-Cell Maturation Antigen (BCMA) are provided as well as methods of depleting BCMA-expressing cells in a patient in need thereof, comprising administering a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof. Methods of treating B cell-related disorders associated with BCMA expression in a patient in need thereof are provided, comprising administering to the patient a therapeutically effective amount of the antibody species or an entity comprising a BCMA binding fragment thereof.
    Type: Application
    Filed: February 20, 2019
    Publication date: December 24, 2020
    Inventors: Mahan Abbasian, Henry Chan, Kandasamy Hariharan, Jeonghoon Sun, Andrew Wurmser
  • SIRP-Alpha BINDING PROTEINS AND METHODS OF USE THEREOF
    Publication number: 20200102387
    Abstract: Provided herein are compositions, methods and uses involving antibodies that specifically bind to signal regulatory protein-? (SIRP?) and modulate the activity of SIRP?.
    Type: Application
    Filed: September 25, 2019
    Publication date: April 2, 2020
    Inventors: Mahan Abbasian, Henry H. Chan, Laure Escoubet, Gustavo Fenalti, Kandasamy Hariharan, Monica Wai Ling Leung, Konstantinos Mavrommatis, David P. Mikolon, Heather K. Raymon, Carlo Steven Santos, Jeonghoon Sun, Christina Valerie Trout